DM.V - Datametrex AI Limited

TSXV - TSXV Delayed Price. Currency in CAD
0.0950
0.0000 (0.00%)
At close: 3:50PM EDT
Stock chart is not supported by your current browser
Previous Close0.0950
Open0.1000
Bid0.0950 x 0
Ask0.1050 x 0
Day's Range0.0950 - 0.1000
52 Week Range0.0100 - 0.2200
Volume373,570
Avg. Volume5,236,782
Market Cap22.202M
Beta (5Y Monthly)4.67
PE Ratio (TTM)N/A
EPS (TTM)-0.0110
Earnings DateAug. 28, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Baystreet

    Stocks in play: Datametrex AI Limited

    Announced a purchase order of 20,000 COVID-19 test kits from a Canadian based mining company (the "Purchaser") ...

  • GlobeNewswire

    Datametrex Announces Another Sale of COVID-19 Test Kits for $850,000 to a Canadian Mining Company

    Datametrex AI Limited (the "Company" or "Datametrex") (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce a purchase order (the "PO") of 20,000 COVID-19 test kits from a Canadian based mining company (the "Purchaser") with operations worldwide. The Company has secured all requested testing kits, swabs, tubes, and the PCR machines. All of the items will be delivered directly to the mining company at their operating site in Latin America in mid-July.

  • GlobeNewswire

    Datametrex Announces $2.6M Sales Agreement

    Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF)  is pleased to announce that it has entered into a sales agreement with SeeS Solutions Inc. (“SeeS”). Under the terms of the agreement, SeeS will utilize Datametrex’s technologies as an automated operating solution for its large corporate customers like Samsung Electronics and Samsung SDI as well as several banks and insurance companies for approximate sales of $2.6 million per annum. The Company continues to work towards establishing partnerships to advance the Companies AI product portfolio and further monetize its value.

  • GlobeNewswire

    Datametrex Introduces Nexalogy “SMART”

    Datametrex AI Limited (the "Company" or "Datametrex") (TSX-V: DM, FSE: D4G, OTC: DTMXF) is pleased to introduce Nexalogy’s Social Media Automated Reporting Technologies (“SMART”). Nexalogy’s SMART is an advanced proprietary AI technology that minimizes human involvement. In a world in conflict and disinformation with the daily expansion of internet technology, AI is an integral tool to decipher this complex digital landscape.

  • GlobeNewswire

    Datametrex Strengthens Board With Appointment of Benj Gallander

    Datametrex AI Limited (the "Company" or "Datametrex") (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce the appointment of Mr. Benj Gallander as a new independent member of the Board of Directors. To support Datametrex’s growth, Mr. Gallander brings over 40 years of experience in the markets, with ample skills in integrating business and strategic investors and his know-how bringing innovation to companies. Mr. Gallander is co-editor of Contra the Heard investment letter and over the past ten years the portfolio he manages achieved an annualized return of 18.4%.

  • GlobeNewswire

    Datametrex Correction of Previous Press Release

    Datametrex AI Limited (the "Company" or "Datametrex") (TSXV: DM, FSE: D4G, OTC: DTMXF) wishes to state that the quote by Pierre Gratton, President and CEO of the Mining Association of Canada, was included in error in its previous press release titled “Datametrex Completes Shipping of Second $500,000 Purchase Order to Canadian Mining Company” from June 24, 2020 as it may be taken out of context. The Company did not intend to imply an endorsement from Mr. Gratton nor the Mining Association of Canada for Datametrex or any of its subsidiaries. Datametrex applauds the efforts of the Mining Association on their prevention measures and respects the commitment of Mr. Gratton of staying neutral in his statements to focus on the issues at hand.

  • GlobeNewswire

    Datametrex Completes Shipping of Second $500,000 Purchase Order to Canadian Mining Company

    Datametrex AI Limited (the "Company" or "Datametrex") (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that the Company has completed shipping the second 10,000 purchase order of COVID-19 test kits (the "PO") to a Canadian based mining company with operations worldwide. The Company also shipped two (2) Real-Time Polymerase Chain Reaction Detection System (“PCR”) machines along with software to ensure optimal assay performance of the samples. “I think our industry has taken COVID-19 extremely seriously,” said Pierre Gratton, President and Chief Executive officer of the Mining Association of Canada to the Financial Post.

  • GlobeNewswire

    Datametrex Sold $1.5m Test Kits and Provides 90 Day Corporate Update on COVID-19 With Sales Outlook

    Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to share a corporate update that since announcing on April 16, 2020, that it secured the rights to import and sell high-quality South Korean manufactured Nucleic Acid COVID-19 test kits. Datametrex continues supporting companies through facilitating COVID-19 test kits, along with big data AI analytics tools that can help target future outbreaks, potentially source fake news that can be detrimental to the operations, or even visualize the audience that needs the fastest response in these critical times. The Company has sold approximately 30,000 test kits and 7 PCR (Polymerase Chain Reaction) machines to several Canadian companies, for total gross sales of approximately $1.5 million CAD.

  • GlobeNewswire

    Datametrex Obtains Rights to Sell COVID-19 Home Test Kits With FDA Registration

    Datametrex AI Limited (the "Company" or "Datametrex") (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has secured non-exclusive rights to sell RapiGEN Inc. (“RapiGEN”) COVID-19 home test kitsi. The RapiGen home test kit is a lateral flow immunochromatographic assay (LFIA) for the qualitative detection of IgG antibodies to COVID19 in blood, serum or plasma specimens. The Company’s primary goal is to sell to the current clients for their operations out of Canada, and the Company intends to apply for Health Canada approval with an Interim Order (“IO”).

  • GlobeNewswire

    Datametrex Received the Final Payment on Completed Shipping of COVID-19 Test Kit Order

    Datametrex AI Limited (the "Company" or "Datametrex") (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that the Company has received the full and final payment from its purchaser and completed shipping the first purchase order (the “PO”) of COVID-19 test kits for a mining company employees in multiple jurisdictions outside of Canada, as announced on May 15th 2020. Under the terms of the PO, Datametrex sold to the purchaser an initial 10,000 units of the iONEBIO Inc. iLAMP Novel-CoV19 Detection Kit; 10,000 3 mL Universal Transport Medium (UTM®) Sterile Swabs with 16x100mm Skirted Tubes with Plastic Red Capture Caps, and 1 Real-Time PCR Detection System machine to analyze the samples. The iONEBIO test kits provide results within approximately 15 to 20 minutes.

  • GlobeNewswire

    Datametrex Announces COVID-19 Test Kits Purchase Orders From a Canadian Health and Safety Company

    Datametrex AI Limited (the "Company" or "Datametrex") (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has received purchase orders (the "PO") for COVID-19 test kits from a Canadian Health and Safety Company. The PO is comprising of 2,000 1 Drop Inc.’s Nucleic Acid test kits, 2,000 Universal Transport Medium (UTM®) Sterile Swabs with 16x100mm Skirted Tubes, 4 Real-Time PCR Detection System machines to analyze the samples, and 1 RNA extractor. Datametrex is ready to supply a strong demand in the North American market for clinically supported COVID-19 test kits.

  • GlobeNewswire

    Datametrex Hires Former LOTTE Executive to Sales Team

    Datametrex AI Limited (the "Company" or "Datametrex") (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that former executive from LOTTE Data Communication Ltd. (“LOTTE”), Edward Choi, joined the Company to head up the sales team in Seoul, South Korea. Edward was a Vice President at LOTTE for leading Lotte’s cyber security division.

  • GlobeNewswire

    Datametrex Announces Sale of COVID-19 Test Kits to Canadian Royalties

    Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has received a purchase order (the “PO”) for COVID-19 test kits from Canadian Royalties Inc. (“CRI”), a Quebec based mining company. Under the terms of the PO, Datametrex will sell to the purchaser an intial 2,000 units of Health Canada authorized COVID-19 qPCR Detection Kits manufactured by 1drop Inc. and 2,000 3 mL Univesal Transport Medium (UTM®) Sterile Swabs with 16x100mm Skirted Tubes with testing being conducted by Transpharm Canada Inc. (“TCI”). The Company has secured all testing kits from the manufacturer required to fulfill the order.

  • GlobeNewswire

    Two COVID-19 Test Kits Distributed by Datametrex Granted FDA Emergency Use Authorization

    Datametrex AI Limited (the "Company" or "Datametrex") (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that Seasun Biomaterial’s 20 minute rapid Nucleic Acid test kit, AQ-TOP COVID-19 Rapid Detection Kit, has received authorization from the U.S. Food & Drug Administration (“FDA”) registered under the Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices (“EUA”). “These test kits can expedite the process of testing by reducing testing times, aiding in an earlier detection of the virus, a more accurate prediction of the positive cases, and a decrease of the infection rate,” said Marshall Gunter, CEO of the Company.

  • GlobeNewswire

    Datametrex Announces Another Sale of COVID-19 Test Kits to a Canadian Mining Company

    Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce a purchase order (the “PO”) of COVID-19 test kits from a Canadian based mining company (the “Purchaser”) with thousands of employees in multiple jurisdictions. This PO is for their Ontario and Quebec operations. Under the PO, Datametrex will provide the Purchaser with 10,000 units of the COVID-19 qPCR Detection Kits manufactured by 1drop Inc., 10,000 3 mL Universal Transport Medium (UTM®) Sterile Swabs with 16x100mm Skirted Tubes, and 2 Real-Time PCR Detection System machine to analyze the samples.

  • GlobeNewswire

    Datametrex Awarded Tender for COVID-19 Test Kits From Canadian Mining Company

    Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has been awarded a tender for COVID-19 test kits from a Quebec based mining company; the Supply Arrangement (the “SA”). Under the SA, the mining company will order an initial 2,000 units of Health Canada authorized COVID-19 qPCR Detection Kits manufactured by 1drop Inc. with testing being conducted by Transpharm Canada Inc. (“TCI”). The Company has secured all testing kits from the manufacturer required to fulfill the order.

  • GlobeNewswire

    Datametrex Reports Government Clearance To Fulfill Its First COVID-19 Test Kit Order

    Datametrex AI Limited (the "Company" or "Datametrex") (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that its purchaser has received Government clearance to fulfill the purchase order (the “PO”) for COVID-19 test kits for its client, a mining company operational in Mali, West Africa. Under the terms of the PO, Datametrex will sell to the purchaser an initial 10,000 units of the iONEBIO Inc. iLAMP Novel-CoV19 Detection Kit; 10,000 3 mL Universal Transport Medium (UTM®) Sterile Swabs with 16x100mm Skirted Tubes with Plastic Red Capture Caps, and 1 Real-Time PCR Detection System machine to analyze the samples. The iONEBIO test kits provide results within approximately 15 to 20 minutes with 99.9% accuracy.

  • GlobeNewswire

    Datametrex Reports First Quarter Results

    TORONTO, May 27, 2020 -- Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce its financial results for Q1, ended March.

  • GlobeNewswire

    Datametrex Enters Strategic Agreement to Help Provide for Processing of COVID-19 Tests for Canadian Companies

    Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that is has signed a Strategic Partnership and Development Agreement (the “Agreement”) with Transpharm Canada Inc. (“TCI”). Under the term of the Agreement TCI will work with Datametrex on scoping out services and providing access to its 25,000 sq. ft state-of-the-art testing facility located in Toronto, ON, to provide support and testing services for COVID-19 testing kits that Datametrex has in its portfolio. Datametrex will be providing the COVID-19 test kits.

  • GlobeNewswire

    Datametrex Adds Pharmacologist Alex MacGregor to the Medical Advisory Board

    Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that President and Dean of the Toronto Institute of Pharmaceutical Technology (“TIPT”) and Clinical Pharmacologist, Dr. Alexander MacGregor, Ph.D., a, has consented to join the Company's Medical Advisory Board. The Company is also in discussion with Transpharm Canada Inc. (“TCI”), the parent company of Toronto Institute of Pharmaceutical Technology to provide lab testing services using there fully compliant Health Canada licensed Good Manufacturing Practice (“GMP”) manufacturing and testing facility located in Toronto, ON, Canada.

  • CNW Group

    IIROC Trading Resumption - DM

    IIROC Trading Resumption - DM

  • GlobeNewswire

    Datametrex Announces Sale of COVID-19 Test Kit to Canadian Mining Company

    Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce it has received a purchase order for (the “PO”) COVID-19 test kits from a Canadian based mining company with over 4,000 employees in multiple jurisdictions outside of Canada. Under the terms of the PO, Datametrex will sell to the purchaser an initial 10,000 units of COVID-19 Detection Kits, comprising of 10,000 3 mL Universal Transport Medium (UTM®) Sterile Swabs with 16x100mm Skirted Tubes with Plastic Red Capture Caps, and 1 Real-Time PCR Detection System machine to analyze the samples. Datametrex anticipates that it will have little or no upfront costs associated with the sale of these test kits.

  • CNW Group

    IIROC Trading Halt - DM

    IIROC Trading Halt - DM

  • GlobeNewswire

    Datametrex Obtains Rights to Sell Health Canada Approved COVID-19 Test Kit

    Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has secured non-exclusive rights to COVID-19 test kits with Health Canada (“HC”) approval, Kingdom of Saudi Arabia, Saudi Food & Drug Authority (“SFDA”) approval, and CE marking certification (“CE”) for European Economic Area (“EEA”) countries, which covers the 27 member states of the EU, the 4 members of EFTA, plus Turkey and the United Kingdom under Brexit. The latest, and fourth kit to be added by Datametrex to distribute is the 1copy™ COVID-19 qPCR Multi Kit (“qPCR kit”), which is Health Canada approved with Authorization Reference Number 312777, Device ID 1020660 and Model No. M22MD100.

  • GlobeNewswire

    Datametrex Obtains Rights to Sell COVID-19 Tests From Two Additional South Korean Manufacturers

    Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has secured non-exclusive rights to sell COVID-19 test kits from two additional South Korean manufacturers, including a kit that is U.S. Food & Drug Administration (“FDA”) approved under Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices (“EUA”) for the United States, and CE marking certification (“CE”) for European Economic Area (“EEA”) countries, which covers the 27 member states of the EU, the 4 members of EFTA, plus Turkey and the United Kingdom under Brexit. According to each of the manufacturers, these test kits made are both Nucleic Acid based, which Health Canada is prioritizing the review of.